Are Screening Tests Reliable to Rule Out Direct Oral Anticoagulant Plasma Levels at Various Thresholds (30, 50, or 100 ng/mL) in Emergency Situations?

Chest. 2018 Jan;153(1):288-290. doi: 10.1016/j.chest.2017.09.047.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage
  • Anticoagulants / blood*
  • Dabigatran / administration & dosage
  • Dabigatran / blood
  • Emergency Treatment / methods
  • Humans
  • Partial Thromboplastin Time
  • Pyrazoles / administration & dosage
  • Pyrazoles / blood
  • Pyridones / administration & dosage
  • Pyridones / blood
  • Reference Values
  • Rivaroxaban / administration & dosage
  • Rivaroxaban / blood
  • Sensitivity and Specificity
  • Thrombin Time

Substances

  • Anticoagulants
  • Pyrazoles
  • Pyridones
  • apixaban
  • Rivaroxaban
  • Dabigatran